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For CD8
 
 
 
 T cells, a relatively short antigen pulse seems sufficient for antigen-presenting 
 
cells to drive clonal expansion and differentiation. It is unknown whether the requirement 
for antigen is similarly ephemeral for CD4
 
 
 
 T cells. To study the dependence of a CD4
 
 
 
 T cell 
 
response on antigen persistence in a quantitatively and temporally controlled manner in 
vivo, we engineered a mouse line expressing a major histocompatibility complex class II–
restricted epitope in dendritic cells under the control of a tetracycline-inducible promoter. 
Experiments tracking the proliferation of CD4
 
 
 
 T cells exposed to their cognate antigen in 
 
various amounts for different time periods revealed that the division of such cells was 
contingent on the presence of antigen throughout their expansion phase, even in the 
presence of an inflammatory stimulus. This previously unrecognized feature of a CD4
 
 
 
 T cell 
 
response contrasts with the proliferative behavior of CD8
 
 
 
 T cells that has been 
 
documented, and it implies that the two T cell subsets might require different strategies for 
efficient vaccination.
 
The exact way in which CD4
 
 
 
 T cell responses
 
 
depend on the orchestrated activity of antigen 
presentation, costimulation, cytokines, and lym-
phocyte  trafficking remains incompletely un-
derstood. In particular, the role that antigen 
plays in the expansion of antigen-specific T cells 
during an immune response in vivo has only 
recently been addressed. On the encounter of 
antigen-presenting DCs in the T lymphocyte 
zones of secondary lymphoid organs, T cells 
proliferate after a latency period of  
 
 
 
24 h. They
divide rapidly and, in parallel, express genes that 
enable them to become completely differenti-
ated effector cells over the following days (1–5). 
Understanding how external signals guide the T 
cells’ internal processes in vivo is critical both 
for better eliciting protective immune responses 
and for interfering with pathological ones.
In the case of CD8
 
 
 
 T cells, it seems that a
 
 
relatively brief engagement of the TCR can be 
sufficient for initiating a program to drive cells 
through multiple rounds of division, as well as to 
acquire effector and memory functions. In a 
 
Listeria monocytogenes 
 
model, CD8
 
 
 
 T cell ex
 
-
pansion continued despite the elimination of live 
bacteria with an antibiotic 24 h after infection 
(6). Similarly, naive CD8
 
 
 
 cells activated for
 
 
2–24 h in vitro and replated without the stimu-
lus divided three to five times over the following 
days (7–10). Importantly, CD8
 
 
 
 T cells stimu
 
-
lated in vitro for 24 h divided at least seven times 
after a subsequent transfer into antigen-free hosts 
(11). Bevan and Fink (12) termed this phenome-
non as being on “autopilot,” alluding to a tran-
scriptional program that is induced on the initial 
antigen encounter and directs the cells toward 
their effector and memory functions without 
further antigenic stimulation. Although this idea 
has recently been challenged by experiments 
performed both in vitro (13) and in vivo (14), 
the current consensus is that the clonal selection 
of CD8
 
 
 
 T cells occurs within a short time span
 
 
of TCR/MHC–peptide engagement.
For CD4
 
 
 
 T cells, the available data are less
 
 
clear. Although an antigen pulse of several hours 
can be sufficient to support subsequent divisions 
(15), continuous antigen exposure considerably 
enhances ongoing proliferation (16–18). Thus, 
for a CD4
 
 
 
 T cell response, it is currently un
 
-
known whether the daughter cells from the first 
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division need to reengage antigen-loaded DCs in the lymph
 
 
node in order to continue dividing and whether clonal selec-
tion occurs during the initial antigen encounter or is a pro-
longed process.
To address antigen dependence during the CD4
 
 
 
 T cell
 
 
expansion phase in vivo, we developed a mouse model in 
which an MHC class II–restricted epitope can be inducibly 
expressed in professional APCs. This model allowed us to 
induce and abrogate the expression of a T cell epitope in 
situ, avoiding potential changes in the APCs’ maturation sta-
tus because of antigen delivery or in vitro manipulation. We 
provide evidence that, rather surprisingly, CD4
 
 
 
 T cells are
 
 
not programmed during the initial antigen encounter to di-
vide a certain number of times, but rather proliferate accord-
ing to the load and persistence of antigen they are exposed to 
throughout the expansion phase.
 
RESULTS
 
Tetracycline (tet)-responsive antigen expression in 
 
professional APCs of transgenic mice
 
To study the influence of antigen dose and persistence on
 
 
CD4
 
 
 
 T cell responses in vivo, we generated double trans
 
-
genic mice expressing an antigenic peptide from moth cyto-
chrome c (MCC) in a reversible manner. We used the tet-
regulatable transgene expression system (Fig. 1 A) that we 
described previously (19). In brief, a first transgenic line 
named TIM (tet-inducible invariant chain with MCC) was 
designed to add the neoself T cell epitope MCC
 
93-103
 
 to the
 
 
natural pool of self-peptides in cells that normally express 
MHC class II molecules. The E
 
k
 
-restricted T cell epitope
 
 
MCC
 
93-103
 
 replaced part of the class II–associated invariant
 
 
chain (Ii) peptide region in order to deliver this antigen to 
the MHC class II loading pathway. The Ii–MCC construct 
was placed under the control of a tet-regulatable promoter.
A second transgenic line carried the improved S2 mutant 
of the reverse tet transactivator (rtTA
 
s
 
-S2; reference 
 
20) un-
der the direction of a hybrid regulatory element consisting of 
the E
 
 
 
 enhancer and the Ii promoter. These control ele
 
-
ments drive reporter gene expression at high levels in MHC 
class II–positive cells of transgenic mice (21). Transactivator 
expression was assessed in mice carrying this transgene (Ii-
rTA) by Northern blot analysis. Like the endogenous invari-
ant chain, the Ii-rTA mRNA was highly expressed in the 
lung, spleen, and thymus and was made at lower levels in the 
Figure 1. dox-controlled expression of a T cell epitope in vivo. 
(A) Schematic view of the double transgenic system. See the first two 
paragraphs of Results for details. (B) dox-dependent TIM reporter gene
expression in lymphoid tissues. mRNA from the lymph nodes, spleen, and 
thymus of Ii-rTA TIM  animals supplied with standard (top) or 100  g/ml 
dox-containing (bottom) drinking water was prepared, and TIM mRNA ex-
pression was assessed relative to HPRT by real-time RT-PCR. Data are from 
two and three animals, respectively (nd, not detectable). (C) In the spleen, 
the TIM reporter gene was mostly expressed in DCs. Splenocytes were 
sorted with mAbs against CD19, CD3, CD11b, and CD11c. cDNA was pre-
pared, and TIM expression levels were determined by real-time RT-PCR 
and normalized to HPRT. Data from three animals are shown. The experi-
ment was repeated twice with similar results. (D) TIM reporter mRNA 
quantitatively regulated by dox in the drinking water. Ii-rTA TIM  animals 
were exposed to the indicated doses of dox for 3 d, mRNA was prepared 
from subcutaneous lymph nodes, and TIM mRNA expression was assessed 
by real-time RT-PCR. Shown are values normalized to Ii-rTA mRNA. Each 
symbol represents a sample from one animal. The data were compiled 
from three independent experiments. (E) On transfer, AND CD4  T cells 
proliferated in Ii-rTA TIM  recipients only in the presence of dox. Lymph 
node cells from AND CD90.1  animals were CFSE labeled and transferred 
into CD90.1  recipients of the indicated genotypes that were treated with 
100  g/ml dox as indicated, and subcutaneous lymph nodes and spleens 
were analyzed 60 h later. The histograms are gated on CD4 CD90.1  cells, 
all other panels are gated on CD4  cells. The experiment was repeated 
with similar results. 
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liver, heart, and kidney (unpublished data). Mice carrying Ii-
 
rTA were crossed with the TIM reporter line, and double 
transgenic animals were administered the tet derivative doxy-
cycline (dox) in their drinking water. This treatment led to 
the expression of the TIM gene, readily detectable by real-
time RT-PCR in the lymph nodes, spleen and thymus, 
whereas no TIM mRNA was observed in the absence of 
dox (Fig. 1 B).
To establish which cell types express the inducible trans-
gene, we sorted different cell populations from the spleens of 
dox-treated, double transgenic animals and quantitated TIM 
mRNA by real-time RT-PCR, relative to the housekeeping 
gene hypoxanthine phosphoribosyltransferase (HPRT). The 
highest level of TIM expression was found in DCs and was 
 
 
 
20 times higher than in macrophages and 50 times higher 
than in B cells (Fig. 1 C). The low level of expression of a 
tet-inducible gene in B cells did not come as a surprise; sev-
eral laboratories, including our own, have tried to achieve a 
tet-regulatable expression of diverse reporter genes in the 
mature B cells of transgenic mice, but have so far failed to do 
so for still obscure reasons (22, 23; unpublished data). How-
ever, because DCs play a pivotal role in CD4
 
 
 
 T cell prim
 
-
ing to exogenous antigens (2, 5), this transgene expression 
pattern is very well suited for studying this process.
Our intention was to create a system in which the ex-
pression of a designated T cell antigen could also be regu-
lated in a quantitative manner. To evaluate this potential in 
the Ii-rTA–TIM system, we provided mice with varied 
amounts of dox in their drinking water and assessed TIM ex-
pression in lymph nodes by real-time RT-PCR. A close 
correlation between the dose of antibiotic and TIM expres-
sion, extending over three orders of magnitude, was found 
(Fig. 1 D). Again, we could not detect any TIM mRNA in 
the absence of dox.
We next exploited the ability of the TIM-encoded anti-
gen to stimulate T cells as a sensitive readout for TIM ex-
pression to (a) establish whether the MCC peptide was ex-
pressed in a stimulatory manner; and (b) test for “leaky” 
expression in the absence of dox, which can hamper the 
proper interpretation of results. Carboxyfluorescein diacetate 
succinimidyl ester (CFSE)-labeled naive T cells from AND 
TCR transgenic mice, which have a T cell repertoire 
skewed for an E
 
k
 
–MCC specificity, were transferred into Ii-
 
rTA
 
 
 
TIM
 
 
 
 double transgenic or nontransgenic control re
 
-
cipients. 60 h after transfer, a vigorous proliferation of such 
cells was observed in the lymph nodes and spleen of dox-
treated recipients. Proliferating AND cells acquired an effec-
tor phenotype by up-regulating CD44 and synthesizing 
IFN-
 
 
 
 (Fig. 1 E, bottom). Such activation was dependent on 
the AND TCR, as T cells of irrelevant specificity were not 
triggered to proliferate (see Fig. 6; unpublished data). In the 
absence of dox, no activation could be detected beyond the 
background observed in the nontransgenic recipient (Fig. 1 
E, top and middle). These data, obtained using the more rel-
evant and sensitive assay of T cell activation, also confirm 
that TIM and E
 
k
 
–MCC expression are absolutely dependent
 
 
on dox.
Finally, the dox requirement for TIM expression was 
verified by analyzing thymi of Ii-rTA
 
 
 
TIM
 
 
 
AND
 
 
 
 animals,
 
 
given that differentiating T cells are exquisitely sensitive to a 
trace amount of antigen. Flow cytometric analysis showed 
that in the absence of dox, thymi from the triple transgenic 
Ii-rTA
 
 
 
TIM
 
 
 
AND
 
 
 
 and from a single transgenic AND an
 
-
imal were indistinguishable (unpublished data). However, 
when dox was present in the drinking water, AND thy-
mocytes did not differentiate to the mature CD4
 
 
 
CD8
 
 
 
 sin
 
-
gle positive stage, indicating a strong negative selection. 
These findings emphasize the absolute dependence of TIM 
transcription on dox in the thymus. Thus, we conclude that 
the expression of the neoself peptide in APCs of this system 
depends on the presence of dox, at least to the extent that 
RT-PCR, mature T cells, and thymocytes can detect it.
Figure 2. T cell responses vary with antigen dose. (A) Lymph node 
cells from AND TCR transgenic mice were CFSE labeled and transferred into 
two double transgenic Ii-rTA TIM  recipients that were exposed through-
out the experiment to drinking water containing dox at the indicated con-
centrations. Lymph node cells were analyzed 60 h later. The plots are gated 
on CD4  cells. (B) T cell activation threshold in vivo. Lymph nodes from the 
animals described in A were also analyzed for Ii-rtTA and TIM mRNAs by 
quantitative RT-PCR. The proportion of divided cells 60 h after transfer was 
determined by dividing the cell numbers in each peak by 2i, with i being the 
division number, and dividing this normalized number of divided cells 
(region 1) by the normalized total (region 2). Each data point stands for one 
animal, with each symbol representing one dose of dox in the drinking 
water (closed black circle, 5; open circle, 10; closed gray circle, 15; closed 
black square, 20; open square, 25; closed gray square, 50; closed black 
triangle,100; open triangle, 50; closed gray triangle, 200 [ g/ml each]). The 
data are compiled from three independent experiments.ANTIGEN REQUIREMENT FOR CD4  T CELL EXPANSION | Obst et al. 1558
How antigen dose affects CD4  T cell proliferation
The possibility of modifying the amount of antigen predom-
inantly expressed by DCs allowed us to ask how antigen 
regulates the expansion of responding CD4  T cells. Ini-
tially, the proliferative response of adoptively transferred 
AND T cells to different amounts of the MCC epitope was 
analyzed. Ii-rTA TIM  animals were exposed to increasing 
amounts of dox in the drinking water, CFSE labeled, AND 
transgenic T cells were transferred into them, and the prolif-
eration of the transferred cells in lymph nodes was analyzed 
60 h later. Although there was some mouse-to-mouse vari-
ability (comparing pairs of cage mates), AND T cell prolifer-
ation increased in a dose-dependent manner (Fig. 2 A). 
Plotting the relative TIM mRNA levels versus the fraction 
of divided cells from the same animal revealed that no pro-
liferation was observed at a low dox dose though TIM 
mRNA was detectable. There was a sharp transition to max-
imum proliferation at intermediate doses of dox, suggesting 
that a threshold of TIM mRNA was required to achieve 
complete T cell activation in vivo (Fig. 2 B). The fact that 
the T cell response appeared to saturate at doses  30  g/ml 
indicates that this system targets antigen presentation effi-
ciently to professional APCs.
A comparison of the CFSE profiles of T cells transferred 
into mice exposed to intermediate and high doses of dox 
(Fig. 2 A) suggested that the amount of antigen not only de-
termined how many T cells entered the cell cycle, but also 
regulated how quickly they proceeded through the follow-
ing divisions. To investigate this dose-dependent control of 
proliferation in more detail, we monitored responses over 
time to graded amounts of antigen. As before, CFSE-labeled 
AND T cells were transferred into double transgenic animals 
that were continuously exposed to various dox concentra-
tions in the drinking water. During the following 6 d, sub-
cutaneous lymph nodes were removed sequentially from a 
given animal, and the dilution of CFSE in AND T cells was 
analyzed. The data depicted in Fig. 3 support the idea that 
antigen dose regulates the magnitude of the T cell response 
by controlling both T cell recruitment into the response and 
the rate of subsequent divisions. First, whereas almost all of 
the AND T cells in animals exposed to 100  g/ml dox had 
already divided two or three times by 36 h, only 50% of the 
antigen-specific cells had divided at all in mice exposed to a 
10-fold lower dox concentration (Fig. 3, A [far left] and B 
[intermediate doses]). Second, many of the T cells in the an-
imal exposed to 10  g/ml dox divided fewer than six times 
and appear to continue cycling even after day 4 (Fig. 3 A). 
The presence of cells induced to divide, but fewer than 
seven times, suggests that the strength of the antigenic signal 
is able to continually have an impact on the course of the 
CD4  T cell response. Such a notion contrasts with the “au-
topilot” idea (12) which argued that CD8  T cells, once re-
cruited into the cell cycle, were set to run through a pro-
grammed number of at least seven divisions independent of 
antigen persistence.
Kinetics of antigen removal
The tet system offered the possibility of directly testing 
CD4  T cells’ continuous dependence on antigen because 
it permitted one to initiate a response and then punctually 
shut off the synthesis and presentation of the MCC epitope. 
It was initially necessary to establish the kinetics of TIM ex-
pression and MCC presentation in Ii-rTA TIM  double 
transgenic animals. Mice were exposed to 100  g/ml dox 
for 24 h to allow for the highest TIM expression without 
variability, and the amount of TIM mRNA in excised 
lymph nodes was assessed at different times after the treat-
ment. A short pulse of dox administration was chosen in or-
der to avoid the potential problem of dox accumulation and 
persistence in tissues during long-term treatment. The max-
imal expression of TIM mRNA in the lymph nodes was 
achieved within 6 h of the exposure of the double trans-
genic mice to dox (Fig. 4 A). TIM transcripts disappeared 
with a half-life of 168 min (2.8 h), a value remarkably close 
Figure 3. The amount of antigen displayed by DCs determines both 
the initial induction of CD4  T cells to proliferate and its rate. (A) At 
a low antigen dose, some CD4  cells divided fewer than six times. Lymph 
node cells from CD90.1  AND TCR transgenic mice were CFSE labeled and 
transferred into Ii-rTA TIM  animals that were supplied with 10, 30, or 
100  g/ml dox starting 2 d before transfer. The control animal (top) was 
an animal transgenic for TIM only and was fed with 100  g/ml dox. Indi-
vidual subcutaneous lymph nodes were removed 36, 60, 84, and 140 h 
after the transfer and analyzed by gating on CD4 CD90.1  cells. Percent-
ages indicate gated cells. (B) Induction of cell division 36 h after transfer 
correlated with antigen dose. The fraction of undivided cells at each time 
point after T cell transfer was calculated as described in Fig. 2 B and plotted 
against the dox dose. (C) Relative cell numbers of antigen-specific cells 
(CD90.1 ) in the CD4  T cell compartment increased corresponding to the 
dox dosage. The experiment was repeated with similar results.  JEM VOL. 201, May 16, 2005 1559
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to the previously reported 170-min half-life of dox in 
mouse serum (Fig. 4 A; reference 24). These data suggest, 
then, that TIM mRNA is quite unstable, turning over 
within minutes, and that its levels track serum dox concen-
trations very closely.
To find out how the biologically relevant gene product, the 
Ek–MCC complex detected by CD4  T cells, disappeared from 
an animal, we supplied double transgenic animals with dox for 
24 h and transferred CFSE-labeled AND T cells into them 0–4 d
later (Fig. 4 B). T cell proliferation was vigorous when cells 
were transferred within 1 d of dox withdrawal. In contrast, few 
cells divided when transferred 2 d or more after dox removal, 
and division was essentially undetectable above background af-
ter 4 d. Based on these data, the half-life of this MHC–peptide 
complex, as detected by in vivo T cells, was  1 d in the subcu-
taneous lymph nodes and spleen (Fig. 4 C). This estimate re-
flects TIM mRNA and protein degradation, antigen processing, 
the survival of the stimulatory MHC–peptide complex at the 
cell surface, and DC longevity. Nevertheless, it was possible to 
effectively shut off most of the CD4  T cell stimulatory capabil-
ity in double transgenic mice within 48 h of dox removal.
Persistence of antigen is required for proliferation and 
effector function
These kinetics provided a system with which to test the in-
fluence of antigen persistence on the course of a CD4  T 
Figure 4. Half-life of TIM mRNA and Ek–MCC93-103 complexes in 
vivo. (A) Ii-rTA TIM  mice were exposed to 100  g/ml dox in the drinking 
water for 24 h (gray bar). Subcutaneous lymph nodes were removed from 
four animals at each time point (except 12 that were taken at 72 h) and 
analyzed for TIM expression relative to Ii-rTA mRNA, as described for Figs. 1 
and 2 (open circle, lymph node; bars, arithmetic means; closed circles, samples 
below the detection limit of the quantitative RT-PCR assay). The disappear-
ance of the TIM mRNA within 24 h after dox withdrawal could be modeled 
by y   3.0e 0.24x. The experiment was repeated twice with similar results (nd, 
not detectable). (B) Double transgenic animals were exposed to 100  g/ml dox 
in the drinking water for 24 h from 0 to 5 d before the transfer of CFSE-
labeled lymph node cells from CD90.1  AND TCR transgenic mice. 60 h 
later, subcutaneous lymph nodes and spleen were analyzed. The histograms 
depict CD4 CD90.1  cells. The experiment was repeated with similar results. 
(C) The proportion of divided cells was quantitated from the data shown in B 
as described for Fig. 2 B, modeled with y   0.89e 0.75x and y   0.87e 0.75x 
for the lymph nodes and spleen, respectively.
Figure 5. Continued proliferation of CD4  T cells depends on anti-
gen persistence. (A) CFSE-labeled lymph node cells from CD45.1  AND 
TCR transgenic mice were transferred into mice that were treated with 
100  g/ml dox for 24 h according to the indicated schedules. All recipi-
ents were double transgenic Ii-rTA TIM , except mouse 1, which carried 
the TIM gene only and was dox treated throughout. Subcutaneous lymph 
nodes were removed 36, 60, 84, and 108 h after transfer and were ana-
lyzed by flow cytometry. The 36-h and 60-h panels are gated on CD4  
cells, the others on CD4 CD45.1  cells. One representative experiment out 
of five independent ones is shown. (B) Mean number of divisions of trans-
ferred cells from experiment A plotted against time is shown. (C) Proportion of 
transferred AND CD4  cells among total CD4  cells in subcutaneous 
lymph nodes from experiment A over time is shown.ANTIGEN REQUIREMENT FOR CD4  T CELL EXPANSION | Obst et al. 1560
cell response. If the presence of antigen does not matter to 
already recruited T cells, proliferation rates would be ex-
pected to be the same in animals from which antigen is re-
moved at different times after the initiation of the response. 
However, this was not the case. AND T cells were labeled 
with CFSE and transferred into Ii-rTA TIM  animals ex-
posed to dox continuously or for 24-h periods, timed as de-
picted in Fig. 5 A. The resulting responses were monitored 
by the serial removal of subcutaneous lymph nodes from a 
given mouse at regular intervals.
In all Ii-rTA TIM  double transgenic recipients, most 
of the AND cells had divided once or twice by 36 h, attest-
Figure 6. Primed CD4  cells require antigen for continued prolif-
eration in a double transfer model and under inflammatory conditions. 
(A) AND cells divide two to four times in a primary host. CFSE-labeled 
lymph node cells from CD90.1  AND TCR transgenic mice were transferred 
into a double transgenic Ii-rTA TIM  recipient pretreated with 100  g/ml 
dox. 24 h later, straight water was given. Another 24 h later, CD4 CD90.1  
lymph node cells were analyzed for CFSE dilution. (B) Primed AND T cells 
require antigen for proliferation in a secondary host. Unlabeled CD90.1  
AND cells were transferred into a double transgenic Ii-rTA TIM  primary 
recipient pretreated with 100  g/ml dox. 24 h later, straight water was 
given. Another 24 h later, the lymph node cells were CFSE labeled 
and transferred into an untreated nontransgenic (top) or a dox-treated 
Ii-rTA TIM  (bottom) secondary host. 60 h later, subcutaneous lymph 
node cells were analyzed by flow cytometry. CFSE profiles of CD4 CD90.1  
cells (left) and CD4 CD90.1  AND cells (right) are depicted. One represen-
tative experiment out of three independent ones is shown. (C) Primed AND 
T cells require antigen for proliferation in a secondary host even under 
inflammatory conditions. The experiment was performed as described in B, 
but 10 nmol of the CpG-containing oligonucleotide 1668 were injected i.p. 
at the time of the first transfer. (D) Continued proliferation of CD4  T cells 
depends on antigen persistence, even if they were primed under inflam-
matory conditions. CFSE-labeled lymph node cells from CD90.1  AND TCR 
transgenic mice were transferred into mice that were treated with 100  g/ml 
dox for 24 h according to the indicated schedules and injected i.p. with 
PBS (left) or 10 nmol of the CpG-containing oligonucleotide 1668 (right). 
Subcutaneous lymph nodes were removed 48, 72, and 120 h after transfer 
and were analyzed by flow cytometry. All panels are gated on 
CD4 CD90.1  cells.  JEM VOL. 201, May 16, 2005 1561
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ing to a TCR engagement sufficient for initiated prolifera-
tion (Fig. 5 A, plotted in B as the number of divisions over 
time). These divisions persisted in the continually treated an-
imal (Fig. 5, A and B, mouse 5), with five divisions occur-
ring by 60 h, and two more by 84 h. However, in the ani-
mals in which dox had been removed at various times, 
proliferation suffered a halt: earliest in mice 2 and 3, later for 
mouse 4 (Fig. 5, A and B). The antigen dependence of T cell 
proliferation was also reflected in the relative number of an-
tigen-specific cells in the lymph node; in addition, early anti-
gen withdrawal could accelerate the contraction phase (Fig. 
5 C). Thus, the number of divisions CD4  T cells under-
went in the first 4 d after the antigen encounter depended on 
antigen persistence at high levels during that time. It appears 
that CD4  T cells stop dividing as soon as the antigen con-
centration falls below a certain threshold.
We independently confirmed the requirement for the 
continuous presence of antigen by applying a second experi-
mental strategy. Congenically marked AND T cells were 
doubly transferred. In the primary recipient, a completely 
induced Ii-rTA TIM  animal, unlabeled cells were exposed 
to antigen for 48 h. This elicited two to four rounds of divi-
sion, which were visualized in a parallel transfer of CFSE-
labeled cells depicted in Fig. 6 A. The cells were then taken
out, CFSE labeled, and transferred into secondary recipients 
that did or did not express the TIM transgene. To minimize 
the contribution of transferred APCs, the primary hosts were 
taken off dox 24 h before the second transfer, a feature of the 
system that made prolonged cell handling for sorting unnec-
essary. The secondary recipients were analyzed 60 h after 
transfer (Fig. 6 B). Here again, continued proliferation in the 
lymph nodes and spleens of the secondary hosts depended on 
antigen being expressed. The cells transferred into an anti-
gen-free secondary recipient appeared to undergo perhaps 
one additional cycle (activated T cells do not label with 
CFSE well enough to allow an accurate estimate), but then 
stopped, whereas the continuous presence of antigen al-
lowed the cells to progress a further four cycles or more (Fig. 
6 B). Even exposures to antigen in the primary host for 60 or 
84 h yielded similar results, indicating that, under these con-
ditions, higher antigenic strength, in the form of longer term 
priming, does not propel CD4  T cells into antigen-inde-
pendent proliferation (unpublished data). These findings 
corroborate the conclusion from the dox-controlled antigen 
turn-off experiment.
We also examined whether an initial T cell encounter 
with activated DCs could alter the antigen dependence of 
CD4  T cell proliferation. The experiment described in the 
previous paragraph was repeated except that the primary 
recipient was injected with DC-activating, unmethylated
CpG-containing oligodeoxynucleotides at the time of T cell 
transfer. This treatment activated DCs, as indicated by the 
up-regulation of costimulatory molecules and the produc-
tion of IL-12 (25, 26; unpublished data). Even under these 
conditions, the AND T cells proliferated in the dox-treated 
secondary recipient, but not in the untreated one (Fig. 6 C), 
indicating that CD4  T cells primed by activated DCs still 
depend on the antigen for continued proliferation. This con-
clusion was supported by removing the antigen by dox 
withdrawal (Fig. 6 D). Ii-rTA TIM  animals were exposed 
to dox as in the experiment depicted in Fig. 5, but injected 
with either PBS- or CpG-containing oligonucleotides at the 
time of dox application so that the Ek–MCC complexes 
would be presented by activated DCs. The CFSE profiles of 
the two groups of animals were virtually indistinguishable 
(Fig. 6 D).
If antigen persistence is required for efficient clonal ex-
pansion, is this also true for the acquisition of effector 
characteristics? Or is the induction of, for example, IFN- 
synthesis, a reporter of productive priming (26–28), pro-
grammed early on antigen encounter and only realized later? 
As before, Ii-rTA TIM  animals were exposed to dox at 
different times relative to the transfer of CFSE-labeled AND 
T cells and analyzed 60 h later. As expected, the cells divided 
further in the animal where antigen persisted longer (Fig. 7). 
Whereas CD44 was expressed on all cells early on, IFN- 
was detected only with continuous antigen exposure (after 
more than five rounds of division). This finding suggests a 
requirement for antigen throughout the response not only 
for the expansion of CD4  T cells, but also for the manifes-
tation of their effector functions.
DISCUSSION
The experiments described here address the issue of whether 
antigen-specific responses by CD4  T cells depend on the 
continued engagement of the TCR by cognate ligand, or on 
the initial conditions in which the antigen is encountered. 
Figure 7. Antigen persistence required for CD4  effector cell dif-
ferentiation. Lymph node cells from CD45.1  AND TCR transgenic mice 
were CFSE labeled and transferred into Ii-rTA TIM  recipients exposed to 
100  g/ml dox in the drinking water for 24 h as indicated and analyzed 
60 h later by flow cytometry. The histograms were gated on CD4 CD45.1  
cells, all other panels on CD4  cells. The experiment was repeated with 
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We developed a transgenic mouse system in which a T cell 
antigen presented by MHC class II molecules presented on 
DCs can be finely regulated in vivo, as a function of the dox 
dose. Expression levels can be set over a 3-log dynamic 
range, and the fast decay of the transgene-encoded mRNA 
permits dynamic control of these levels. This system allowed 
us to evaluate the role of antigen in tuning the response in 
vivo. Because the supply of MHC class II–binding peptide is 
the sole variable in the system, CD4  T cell responses could 
be studied in the absence of contributions from CD8  T or 
B cells. We found that CD4  T cell proliferation depended 
on, and continuously adjusted to, antigen persistence through-
out the expansion phase.
When antigen was encountered at a low dose, three pa-
rameters varied relative to stimulation with a maximally ef-
fective dose: the induction of cell division was retarded, it 
involved fewer cells, and the progression through successive 
division cycles was slower (Fig. 3). Delayed, less frequent, 
and slower entries into the cell cycle was somewhat ex-
pected. The dampening of these parameters can be explained 
by the low frequency with which T cells encounter DCs 
that present sufficient numbers of peptides to activate them 
and a lower probability of reaching an activating threshold 
leading to the observed delay. This interpretation implies 
that antigenic signals can be read sequentially and somehow 
integrated over time, perhaps by building up the amount of 
an intracellular mediator (29, 30). One caveat to this inter-
pretation might be that we do not currently have precise 
information on how lower dox concentrations regulate anti-
gen presentation. It is possible that the number of TIM-ex-
pressing APCs is diminishing and/or the number of relevant 
Ek–MCC complexes is being homogenously reduced on all 
DCs. Based on our previous studies using the tet system, we 
anticipate the latter to be the case (19, 31).
On the other hand, the observation that a low dose of 
peptide caused a slower rate of proliferation of those cells 
that had entered the cell cycle was less expected. Kaech and 
Ahmed (11) suggested that the proportion of cells induced to 
divide is the only limiting step controlling the magnitude of 
a CD8  T cell response, with each cell running on “autopi-
lot” once cycling has been initiated (12). Here, we showed 
that a lower antigenic stimulus made for a slower pace of 
CD4  T cell division. Whereas cells that encountered high 
amounts of antigen ran as tight populations through highly 
synchronized divisions, the CFSE profiles at low doses were, 
even after 4 d of stimulation, spread out over at least seven 
divisions (Fig. 3). Thus, it appears that the dividing cells still 
relied on antigen for proliferation and did not merely exe-
cute a program set in place soon after antigen encounter.
The proposition that the vigor with which activated 
CD4  T cells cycle is controlled by the degree of continu-
ous TCR triggering was tested most directly by antigen 
withdrawal. Removing the antigenic stimulus by punctual 
gene turn-off or by the transfer of antigen-stimulated T cells 
into antigen-free hosts led to quite an abrupt cessation of 
proliferation, with no sign of TCR-independent prolifera-
tion of previously activated CD4  lymphocytes. In the 
transfer experiments, for example, proliferating cells ap-
peared to merely finish the one cycle in which they were 
engaged (Fig. 6). This strict antigen dependence of the 
CD4  response came as some surprise, in light of several in 
vitro experiments that showed antigen-independent cell di-
vision after an initial antigen pulse and emphasized the im-
portance of cytokines in supporting continued division (15–
17, 32). These results were slightly unclear, however, as an 
influence of continued TCR engagement was also detected 
in some of these and other studies (15–18). Although cyto-
kine requirements, which our experiments did not address, 
might also play an important role in regulating the expan-
sion phase in vivo, the present results demonstrate that the 
continued engagement of the TCR is a key element con-
trolling the in vivo response of CD4  T cells. These results 
are consistent with recent findings using the L. monocytoge-
nes model, which propose that engendering a maximal 
CD4  T cell response requires a longer window of infec-
tion unmitigated by antibiotic intervention than does a 
CD8  T cell response (33, 34).
It is interesting to consider our conclusion in light of re-
cent observations using time-lapse two-photon microscopy 
on T cell–DC interactions in lymph nodes. In the absence of 
antigen, T cells make transient contacts with multiple DCs 
in the T cell zones of secondary lymphoid organs (35–38). 
When antigen is present, these interactions are prolonged 
(37, 39) and are probably accompanied by increased Ca2 
levels in the T cells (36). During the following 3–24-h time 
interval, long-lasting T cell–DC clusters ( 60 min) can be 
observed; this was followed by the resumption of shorter 
contacts and cell division (37, 39). Our data would suggest 
that the T cell–DC interactions that occur from 30 h on-
wards, although less intense than those provoked by the ini-
tial encounter with cognate antigen, are no less important 
for the continuation of an effective response.
The original autopilot idea, proposed in the context of 
CD8  T cell responses, portrayed antigen recognition exclu-
sively as the initiator of the immune response. A brief expo-
sure (2–24 h, depending on the system) activated a genetic 
program that empowered the antigen-specific T cells and 
their progeny to proliferate and acquire effector functions 
quite autonomously over the following days. Only extrinsic 
factors like cytokines and other mediators would contribute 
to the second phase of expansion (6–9, 11, 12). Why is there 
a difference with the present data? Trivial explanations might 
rest on the different experimental systems used, and it would 
be important to test the responses of CD8  T cells in an 
analogous system. Although we acknowledge this caveat, we 
favor the conclusion that CD4  and CD8  T cells differ in a 
fundamental aspect of their activation by antigen: CD8  T 
cells slide into autopilot, whereas CD4  T cells “stay on 
manual” by continuously adjusting the extent of their re-
sponse to the parameters of antigen presentation.  JEM VOL. 201, May 16, 2005 1563
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There are a number of precedents for CD4  and CD8 
T cells differing in their responses to antigenic challenge 
(40). In responses to pathogens that access both the classical 
MHC class I and II antigen presentation pathways, the num-
ber of specifically activated CD8  cells exceeds those of 
CD4  cells (influenza [41], LCMV [42], vaccinia [43], Sen-
dai [44], L. monocytogenes [33, 45], and EBV [46, 47]). The 
proliferation of naive CD8  T cells in lymphopenic hosts is 
generally more vigorous than that of CD4  cells (48). CD8 
T cells also develop effector functions more readily. For ex-
ample, 8 d after an L. monocytogenes infection, 85% of specific 
CD8  but only 7% of CD4  T cells produced IFN-  (45). 
Finally, costimulatory requirements, via members of the 
CD28 or TNF receptor family appear different; CD4  T cell 
responses are more hampered by compromised signals via 
CD28, CD40, or Ox40L than CD8  T cells and vice versa 
for 4-1BB (49, 50). It is tempting to speculate that these di-
vergent behaviors are caused by a common molecular mech-
anism that early on uncouples the cell cycle from TCR and 
costimulatory input in CD8  but not CD4  T cells, and 
programs the responding cells to divide a preset number of 
cycles and to differentiate quickly into effectors.
Why would the proliferation of CD4  T cells be depen-
dent on the continued presence of antigen, whereas that of 
CD8  T cells appears not to be? Teleologically, it makes 
sense that cells with a helper and gatekeeper role in the im-
mune response be more tightly controlled by the presence of 
antigen than the more effector-focused CD8  T cells. One 
of the functions of CD4  T cells is to activate DCs via the 
CD40-CD154 interactions for efficient CD8  T cell prim-
ing (51, 52). Implicit in the high degree of antigenic control 
over the CD4  response is that tresponse is indirectly main-
tained adequate to the antigenic challenge. It has been re-
ported using several systems that DCs are swiftly eliminated 
or inhibited by CD8  T cells as soon as the latter acquire 
their effector functions (53–56). CD4  Th1 cells, on the 
other hand, have been shown to increase the DCs’ longevity 
via CD40–CD40L interactions (57) and to render DCs resis-
tant to CD8  T cell–mediated killing by up-regulating the 
granzyme B inhibitor SPI-6 (58). Thus, keeping the activa-
tion and numbers of CD4  T cells tied to the antigenic load 
ensures that the ensemble of CD4  T cells, CD8  T cells, 
and DCs responds adequately.
MATERIALS AND METHODS
Transgenes.  The TIM transgene consists of seven tetO sequences, a 
CMV minimal promoter, rabbit  -globin intron 2, the mouse invariant 
chain cDNA in which amino acids 88–89 have been replaced by MCC93–103
(DLIAYLKQATK), and the rabbit  -globin 3 -UTR with a poly(A)   
RNA site. Its generation has been previously described (19). For the Ii-rTA 
transgene, the rTAS-S2 open reading frame from the plasmid pUHD52-1 (a 
gift from H. Bujard [University of Heidelberg, Heidelberg, Germany] and 
W. Hillen [University of Erlangen, Erlangen, Germany]) was cloned into 
pBS and from there via ClaI sites into pDOI-6 (21). The resulting pDOI6-
rtTAS-S2 plasmid contains the E k enhancer, the Ii promoter, its first exon 
(with three ATGs removed) and intron, the rTAS-S2 open reading frame, 
and a rabbit  -globin exon 3 with a poly(A)  RNA site.
Mice.  Part of the pBR322 backbone was removed from the pDOI6-
rtTAS-S2 plasmid, and the resulting fragment was injected into FVB/N oo-
cytes. Four independent lines were generated and transactivator expression 
in different tissues was assessed by Northern blot. Its expression in the liver 
was found to vary among the lines and the one with the lowest liver expres-
sion was backcrossed with C57BL/6 (The Jackson Laboratory) five times 
and crossed with the TIM line. A dox-dependent TIM expression in the 
thymus and spleen was found by RT-PCR for all lines. Double transgenic 
animals were backcrossed at least five generations to B10.BR (The Jackson 
Laboratory) for experiments. AND TCR transgenic mice (gift from S. He-
drick, University of California, San Diego, San Diego, CA; reference 59) 
and maintained on the B10.BR background. AND TCR transgenic animals 
congenic for the CD45.1 and CD90.1 markers were generated by introduc-
ing the loci from B6.SJL-PtprcaPep3b/BoyJ and B6.PL-Thy1a/CyJ animals 
(The Jackson Laboratory), respectively. Animals were treated with dox 
(Sigma-Aldrich) by adding the indicated concentrations to the drinking wa-
ter, including 40 mg aspartame (Equal; reference 60). Bottles were ex-
changed every 3 d. All animals were housed and bred under specific patho-
gen-free conditions at the Harvard Medical School Center for Animal 
Research and Comparative Medicine, and experiments were conducted in 
compliance with federal and institutional guidelines and with the approval 
of the Institutional Animal Care and Use Committee at Harvard University.
CFSE labeling and cell transfer.  Lymph node cells from AND animals 
were resuspended at 20   106 cells/ml in 37 C Ca2 -Mg2 –free PBS with 
0.1% BSA, and 2  l/ml 5 mM CFSE (V-12883; Molecular Probes) in 
DMSO was added while vortexing. Cells were incubated for 10 min at 
37 C, resuspended in cold RPMI 1640 with 10% FCS, and washed five 
times in DMEM before i.v. transfer of the equivalent of 2–4   106
V 3 CD4  cells into recipients. In one experiment, 10 nmol of the unmeth-
ylated CpG-containing oligodeoxynucleotide 1668 was injected i.p. (25).
Surgical removal of lymph nodes. s.c. inguinal and brachial lymph
nodes were surgically removed from anesthetized mice (50  g/g ketamine 
[Bedford Laboratories]; 10  g/g xylazine [Lloyd Laboratories]) via a 5-mm 
incision in the skin. The wound was closed with a 9-mm Reflex wound clip 
(Roboz Surgical Instruments), and the animal was treated with an analgesic 
(2.5  g/g Flunixamine; Fort Dodge Animal Health) after the procedure and 
again 12 h later. Lymph nodes were transferred to cold medium for flow cy-
tometry analysis or were snap frozen in liquid N2 for RNA analysis.
Flow cytometry.  Lymph node and RBC-lysed spleen suspensions were 
preincubated with 2.4G2 culture supernatant to block Fc-  receptor bind-
ing, stained in DMEM, 10 mM Hepes, and 2% FCS, and analyzed on a cy-
tometer (model Coulter XL) using Expo32 software (both from Beckman 
Coulter). ModFit software (Verity) was used to quantify CFSE peaks. Cells 
were sorted on a MoFlo cell sorter with Summit software (DakoCytoma-
tion). mAb’s (BD Biosciences unless indicated otherwise) used were as fol-
lows: CD3 (17A2), CD4 (RM4-5), CD11b (M1/70.15; Caltag), CD11c 
(HL3), CD19 (ID3), CD44 (IM7), CD45.1 (A20), CD62L (MEL-14), 
CD90.1 (HIS51; eBioscience), and CD90.2, and FITC-labeled anti-mV 3 
(KJ25; purified and labeled in the laboratory). Intracellular staining was per-
formed with the CytoFix/CytoPerm kit (BD Biosciences) using anti–
mIFN-  (XMG1.2) and an isotype control (R3-34; BD Biosciences).
RNA preparation and real-time PCR.  RNA from sorted cell popula-
tions was isolated using TRIzol (Invitrogen) following the manufacturer’s 
instructions. From frozen organs, RNA was isolated by a modified LiCl 
method (61). Organs were homogenized first for 30 s in 2 ml 3 M LiCl/6 M
urea/10 mM NaOAc, pH 5.2, plus 50  l with 20% SDS using a high 
speed Polytron homogenizer (Kinematica). After incubating for  12 h at 
4 C, the solution was centrifuged for 10 min at 12,000 g, and the pellet was 
resuspended in 3 M LiCl/6 M urea/10 mM NaOAc, pH 5.2, incubated for 
 30 min at 4 C, and centrifuged as before. The pellet was resuspended in 
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 g/ml proteinase K (freshly added from 20 mg/ml stock; Roche) and incu-
bated 30 min at 37 C. RNA was extracted with phenol/chloroform, etha-
nol precipitated, DNA removed with the DNA-free kit (Ambion), and ran-
domly primed cDNA was prepared with M-MLV-RT using standard 
procedures. Real-time PCR was performed using TaqMan universal PCR 
master mix (Applied Biosystems) and the following oligos and probes: 
HPRT-sense (GAC CGG TCC CGT CAT GC), HPRT-antisense (CAG 
TCC ATG AGG AAT AAA CAC TTT TTC), HPRTP-probe (VIC-
CCG CAG TCC CAG CGT CGT GAT T-TAMRA), rTAS-S2-sense 
(TAG AGG GAT CCG CCC TAG A), rTAS-S2-antisense (CAT GGT 
GAA TTC GAT ATC AAG CTT), rTAS-S2-probe (FAM-CAC GGC 
TGC ACC TTT CTG GC-TAMRA), TIM-sense (GGA TCC TGA 
GAA CTT CAG GCT C), TIM-antisense (TTG GTC ATC CAT GGC 
TCT AGC), and TIM-probe (FAM-AAC GTG CTG GTT GTT GTG 
CTG TCT CAT C-TAMRA). Samples were analyzed on Prism 7700 (Ap-
plied Biosystems) or Mx3000p (Stratagene) instruments with 55 C as an an-
nealing temperature, except for TIM with 60 C.
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